1/
There have been several small RCTs over the last weeks suggesting a clinical benefit for #ivermectin for #COVID_19.

It’s time for a MEGA THREAD on ivermectin, aka the “wonder drug”!

Let's start the show !🔥🔥🔥
2/
Ivermectin belongs to the family of avermectins, which are natural fermentation products of soil bacteria. A Nobel Prize of Medicine was awarded for their discovery.
4/
For example, Anopheles mosquitoes who bite humans or animals treated by ivermectin don’t survive long. Hence the idea to regularly distribute massively ivermectin to humans and livestock in malaria-endemic areas for vector control! https://bohemiaconsortium.org/ 
5/
Ivermectin is active in vitro against several RNA viruses, including flaviviruses.

It was actually evaluated for dengue in a Phase III randomized clinical trial in Thailand. Virological efficacy was demonstrated, but no clinical efficacy was shown.
http://www.rcpt.org/abstractdb/media/abstract/CON2018/Best%20Resident27/BRA_77_Eakkawit.pdf
6/
Ivermectin is active against SARS-CoV-2, but the in vitro study in Vero Cells earlier this year found an EC50 that projected an unhittable dose. The methodology of this study has been criticized though. https://twitter.com/__ice9/status/1328303108615790592
8/
Of note, recent animal in vivo studies for COVID-19 have given positive results.

Latest example here, by researchers from @institutpasteur https://twitter.com/julienpotet/status/1330827131392307200
9/
Now let’s have look at clinical data.

Remember that one of the first papers reporting positive results for ivermectin against COVID-19 was a flawed Big Data study by researchers affiliated to Surgisphere. So this paper doesn’t count. https://twitter.com/martinenserink/status/1268639646113763331
10/
A retrospective study suggesting a benefit for ivermectin was conducted in Miami, USA in March-May 2020. Lower mortality was found in the group of hospitalized COVID-19 patients receiving ivermectin. https://twitter.com/julienpotet/status/1270369217158791168
11/
Multiple small studies of ivermectin were then launched:
➡️some observational / others randomized,
➡️low dose / high dose,
➡️monotherapy / in combination
➡️prophylaxis / treatment

Heterogeneity++. Unclear if it will be possible to conduct a meta-analysis…
12/
Many observational studies have been published, most often with positive results.

Ivermectin has also been used extensively in several countries in Latin America.

But I will now focus on studies coming from randomized clinical trials.
14/
In sum, the vast majority of RCTs of ivermectin-containing regimens for COVID-19 had positive results.

Word of caution: most of these studies have been published as preprints (not yet peer-reviewed). These papers need to be reviewed carefully to identify possible biases.
17/
I forgot to mention an important point: ivermectin is a cheap 💊 available as generics in many countries.

There is also a donation program by @Merck for NTDs ( @MectizanMDP). But I don’t think Merck has shown interest (yet) for the repurposing of ivermectin for COVID-19.
18/
One last word. In the aftermath of the HCQ debacle, policy-makers are nervous when alleged miracle drugs for COVID-19 are praised in social media.

Fair enough...But please don’t censor groups who are discussing potential benefits of ivermectin! https://twitter.com/Covid19Critical/status/1335653346603098113
19/
All these results put together call for urgent implementation of large scale RCTs of ivermectin for COVID-19. At what dose? In combination with another drug? To be discussed.

In any case, it is high time to seriously consider #ivermectin for #COVID_19.
20/ END
#TropMed aficionados, if you have noticed a mistake in this thread about ivermectin for COVID-19, please feel free to correct me !
@carlos_chaccour @dr_michaelmarks @oriolmitja @PeterHotez @mwelentuli @DNDi @LSTM_NTDs @_Isra_Cruz @RSTMH @COR_NTD @SpringGombe @BangertMat
You can follow @julienpotet.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.